Form 8-K - Current report:
SEC Accession No. 0001144204-19-045535
Filing Date
2019-09-23
Accepted
2019-09-23 06:06:01
Documents
13
Period of Report
2019-09-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv529883_8k.htm   iXBRL 8-K 38367
2 EXHIBIT 10.1 tv529883_ex10-1.htm EX-10.1 144744
  Complete submission text file 0001144204-19-045535.txt   394872

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA srne-20190920.xsd EX-101.SCH 3223
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE srne-20190920_lab.xml EX-101.LAB 33476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srne-20190920_pre.xml EX-101.PRE 21983
9 EXTRACTED XBRL INSTANCE DOCUMENT tv529883_8k_htm.xml XML 3490
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

EIN.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36150 | Film No.: 191106209
SIC: 8731 Services-Commercial Physical & Biological Research